The impact of pharmacists' interventions in female internal medicine ward at university-based hospital on cost savings and cost avoidance (TJPS-2021-0306.R2)
Abstract
Background: Several studies have been conducted regarding the role of clinical pharmacist in the reduction of medical costs, the impact of clinical pharmacists in internal medicine wards on cost saving had been rarely studied.
Objective: To define the characteristics of DRPs and evaluate the effect on cost savings and cost avoidance by clinical pharmacists in female internal medicine ward at Songklanagarind Hospital.
Methods: A retrospective analysis of pharmacists’ interventions recorded over a period of 6 months was conducted. DRPs were categorized based on Pharmaceutical Care Network Europe (PCNE) V9.00. The interventions that were accepted then calculated for cost saving and cost avoidance using the perspective of the healthcare institution.
Results: A total of 117 DRPs were evaluated. More than 50% of DRPs only had potential of harm, were detected, and managed by clinical pharmacist before reach the patient. The 97 cases were accepted and implemented by team. The cost saving and cost avoidance were 214.26 USD and 21,697.35 USD, respectively. The highest total saving was from medication reconciliation, followed by dose adjustment. The largest cost reductions recorded were from antibiotic agents.
Conclusions: Medication reconciliation and dose adjustment, especially antibiotic agents were the major role of clinical pharmacists for cost saving.
Objective: To define the characteristics of DRPs and evaluate the effect on cost savings and cost avoidance by clinical pharmacists in female internal medicine ward at Songklanagarind Hospital.
Methods: A retrospective analysis of pharmacists’ interventions recorded over a period of 6 months was conducted. DRPs were categorized based on Pharmaceutical Care Network Europe (PCNE) V9.00. The interventions that were accepted then calculated for cost saving and cost avoidance using the perspective of the healthcare institution.
Results: A total of 117 DRPs were evaluated. More than 50% of DRPs only had potential of harm, were detected, and managed by clinical pharmacist before reach the patient. The 97 cases were accepted and implemented by team. The cost saving and cost avoidance were 214.26 USD and 21,697.35 USD, respectively. The highest total saving was from medication reconciliation, followed by dose adjustment. The largest cost reductions recorded were from antibiotic agents.
Conclusions: Medication reconciliation and dose adjustment, especially antibiotic agents were the major role of clinical pharmacists for cost saving.
Full Text:
335-340;PDFRefbacks
- There are currently no refbacks.